18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT
Abstract Background The aim of this study was to evaluate the efficacy of fluorine 18 (18F) labeled fibroblast activation protein inhibitor (FAPI) in identifying mediastinal and hilar lymph node metastases and to develop a model to quantitatively and repeatedly identify lymph node status. Methods Tw...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2024-01-01
|
| Sarja: | European Journal of Medical Research |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s40001-023-01494-9 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|